MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹1,730 Cr | ₹1,538 Cr | ₹848 Cr | ₹576 Cr | ₹388 Cr |
What is the latest Sundry Debtors ratio of MANKIND PHARMA ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹1,730 Cr |
| Mar2025 | ₹1,538 Cr |
| Mar2024 | ₹848 Cr |
| Mar2023 | ₹576 Cr |
| Mar2022 | ₹388 Cr |
How is Sundry Debtors of MANKIND PHARMA Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,730 Cr | 12.43 | |
| Mar2025 | ₹1,538 Cr | 81.35 | |
| Mar2024 | ₹848 Cr | 47.16 | |
| Mar2023 | ₹576 Cr | 48.50 | |
| Mar2022 | ₹388 Cr | - | |
Compare Sundry Debtors of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹91,562.1 Cr | -2.6% | -10.6% | -7.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -1% | -5.5% | 5.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹238,497.0 Cr | -2.6% | -3.9% | 38.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹170,481.0 Cr | -1.7% | -10.2% | 30.5% | Stock Analytics | |
| CIPLA | ₹108,012.0 Cr | 0.9% | -3.2% | -15.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,207.0 Cr | -0.6% | 1% | -0.1% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -2.6% |
-10.6% |
-7.3% |
| SENSEX | -1.6% |
-2.3% |
-11.5% |
You may also like the below Video Courses